Skip to content

Program Design & Consultation

Strong injectable and combination-product programs begin with design rooted in technical truth. Novocol Pharma partners early to evaluate feasibility, guide device and formulation fit, and shape development paths that anticipate real manufacturing, quality, and regulatory demands. Our SMEs and technical PMs help our customers move forward with clarity and confidence.

Speak with Our Team

Early Feasibility Assessment That Guides Confident 
Program Planning

Before timelines are set or materials are purchased, Novocol Pharma brings the right experts together to pressure-test the fundamentals of a program. Instead of a checklist, feasibility at Novocol Pharma works like a diagnostic. SMEs assess the interplay of formulation, device, and manufacturing realities to identify what is possible, what is likely, and what must be addressed to avoid costly adjustments later.


Our feasibility-driven design process includes:


Technical and operational assessments led by cross-functional SMEs

Device to drug compatibility evaluation for cartridges and PFS

Analysis of volume, viscosity, and delivery configuration constraints

Resource and workstream modeling for internal and external alignment

Phase-appropriate planning for formulation, analytical, and manufacturing needs

Identification of quality, regulatory, technical and supply chain risks

Expertise tailored to cartridge and PFS programs that require deep hardware insight

Solving the Common Challenges in Injectable and Combination-Product Development

Injectable and combination-product programs often encounter challenges that reveal themselves only after work begins. Novocol Pharma helps clients anticipate these issues early so they can avoid costly delays, redesign, or misaligned expectations.

Explore Formulation & Development Services

Common Challenges

Platforms or formulations that are not device-ready

How Novocol Pharma Solves Them

Early feasibility analysis with SMEs to assess device to drug fit and configuration requirements

Common Challenges

Dose form, viscosity, or concentration constraints that affect manufacturability

How Novocol Pharma Solves Them

Design for manufacture guidance built on cartridge and PFS filling expertise

Common Challenges

Operational limitations across fill lines, inspection, supply chain, or aseptic strategy

How Novocol Pharma Solves Them

Realistic capacity and scheduling models based on proven operational data

Common Challenges

Regulatory expectations that must align with your development stage

How Novocol Pharma Solves Them

Deep familiarity with FDA, Health Canada, and ISO requirements to shape phase-appropriate plans

Common Challenges

Cross-functional coordination across analytical, formulation, engineering, quality, and device teams

How Novocol Pharma Solves Them

Integrated planning driven by a technical PM who unites all functions into one executable strategy

Strategic Device and Delivery System Guidance for Cartridges and PFS


Device choice affects almost every downstream decision. Novocol Pharma’s role is to help our clients understand these implications early by analyzing how formulations behave within cartridges, pens, and PFS systems. Instead of evaluating components in isolation, we examine how material attributes, mechanical performance, manufacturability, and patient usability converge.

Break-loose and glide-force performance, siliconization, plunger design, needle and stopper selection, machinability, and supplier reliability are considered within the broader context of feasibility and long-term scalability. This integrated perspective supports device decisions that hold up through development, validation, and commercial production.


Learn More About Device Assembly & Packaging

Project Management Led by Technical Expertise


Our project management at Novocol Pharma functions less like coordination and more like orchestration with high-touch approach for our clients. Each program is led by a technical PM who understands the science, the process, and the operational constraints. This model ensures alignment from the first discussion through scale-up by anticipating questions, challenging assumptions, and maintaining visibility across all workstreams.

Communication rhythms, cross-functional engagement, established risk pathways, and continuity across phases mean progress is tracked, issues are surfaced early, and clients always understand where they stand. Many of our PMs have a long tenure at Novocol Pharma, giving them a level of site and system familiarity that strengthens both strategy and execution.


Learn More About Novocol Pharma

Program Design and Consultation Capabilities

Feasibility and planning support at Novocol Pharma covers the full spectrum of early-stage development needs that influence downstream success.


Feasibility and scope assessment
Device to drug compatibility evaluation
Scale-up and process planning
Phase-appropriate roadmap development
Regulatory and quality impact forecasting
Tech transfer readiness and documentation planning
Cross-functional PM integration

Supporting Technologies and Facilities for Stronger Program Foundations


Novocol Pharma’s ability to guide early-stage design is anchored by the infrastructure of a mature sterile manufacturing environment. Our team draws from active development work, analytical depth, and operational insight to shape feasible, scalable plans.

Key assets supporting program design include multiple cartridge and PFS lines, flexible automation-enabled systems, a 200,000 square foot sterile manufacturing campus, and a development organization actively managing more than 15 concurrent CDMO work packages.


Discover Our Facilities

Let's bring your project to the finish line.

Partner with a team dedicated to precision, reliability, and care at every step.
Start Your Project